Avalo Therapeutics (AVTX) Accounts Payables (2014 - 2026)
Avalo Therapeutics' Accounts Payables came in at $3.35 million for Q2 2026, up 41.5% from $2.37 million a year earlier and up 840.2% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Accounts Payables (2014 - 2026) Analysis & Trends
At the end of FY2025, Avalo Therapeutics' Accounts Payables was $137,000, down 51.6% from FY2024.
- Accounts Payables has declined in each of the last four years, with a five-year compound annual growth rate of -44.4% (FY2020 to FY2025).
- Going back by year, Accounts Payables was $283,000 in FY2024 (-36.5%), $446,000 in FY2023 (-84.5%), $2.88 million in FY2022 (-14.5%) and $3.37 million in FY2021 (+30.9%).
- The Q2 2026 figure represents the highest quarterly Accounts Payables since Q1 2023.
- Year-over-year, Accounts Payables increased in three of the last eight quarters, with growth averaging 24.7%.
- The fastest year-over-year change in Accounts Payables over five years came in Q2 2025 (growth of 261.8%), and the weakest in Q4 2023 (a decline of 84.5%).
- Business Quant data shows AVTX's Accounts Payables at $356,000 (Q1 2026), $137,000 (Q4 2025) and $474,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Avalo Therapeutics | 668.42 Mn | 668.42 Mn | - | 3.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.35 Mn |
| Mar 31, 2026 | 356,000.00 |
| Dec 31, 2025 | 137,000.00 |
| Sep 30, 2025 | 474,000.00 |
| Jun 30, 2025 | 2.37 Mn |
| Mar 31, 2025 | 681,000.00 |
| Dec 31, 2024 | 283,000.00 |
| Sep 30, 2024 | 1.81 Mn |
| Jun 30, 2024 | 654,000.00 |
| Mar 31, 2024 | 916,000.00 |
| Dec 31, 2023 | 446,000.00 |
| Sep 30, 2023 | 789,000.00 |
| Jun 30, 2023 | 751,000.00 |
| Mar 31, 2023 | 5.57 Mn |
| Dec 31, 2022 | 2.88 Mn |
| Sep 30, 2022 | 1.45 Mn |
| Jun 30, 2022 | 2.16 Mn |
| Mar 31, 2022 | 3.76 Mn |
| Dec 31, 2021 | 3.37 Mn |
| Sep 30, 2021 | 3.57 Mn |
API Access
Avalo Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();